Chronic Hepatitis C Treatment with New Antiviral Agents
Recent advances in our knowledge of hepatitis C virus (HCV) molecular biology have enabled improvements in the efficacy and tolerability of HCV treatment, and in this regard many direct-acting antiviral (DAA) agents have been developed. These drugs target specific stages in the HCV life cycle. Phase...
Main Author: | Özlem KANDEMİR |
---|---|
Format: | Article |
Language: | Turkish |
Published: |
Galenos Yayinevi
2018-12-01
|
Series: | Mediterranean Journal of Infection, Microbes and Antimicrobials |
Subjects: | |
Online Access: | http://mjima.org/text.php?&id=114 |
Similar Items
-
New drugs in the treatment of chronic hepatitis C
by: R. Jimenez Galan, et al.
Published: (2014-04-01) -
New treatment of hepatitis C (Direct Acting Antiviral)
by: Mohsen Akhondi-Meybodi
Published: (2019-10-01) -
Management of hepatitis C viral infection in chronic kidney disease patients on hemodialysis in the era of direct-acting antivirals
by: Soon Young Ko, et al.
Published: (2018-12-01) -
Barriers to treatment of chronic hepatitis C with direct acting antivirals in an urban clinic
by: Miguel Malespin, et al.
Published: (2019-03-01) -
The evaluation of liver fibrosis regression in chronic hepatitis C patients after the treatment with direct-acting antiviral agents – A review of the literature
by: Olga H. Orasan, et al.
Published: (2019-10-01)